Whitehall-Robins
This article was originally published in The Tan Sheet
Executive Summary
Association between cough products - "including Robitussin CF" - and increased risk of lung infection or airway blockage "has not been scientifically established," OTC marketer declares in response to August Consumer Reports on Health article. CR review of OTC safety noted Whitehall's product does not carry label warnings on possible risk (1"The Tan Sheet" Aug. 13, In Brief). "Any reported link between cough products and lung infection/airway blockage is anecdotal at best," Whitehall maintains, adding it is "unfair and misleading to single out Robitussin CF as potentially causing these complications." Firm also defends warning language on Advil Cold & Sinus, which was cited by CR